sec filing
PH
NASDAQ · PHAT
Phathom Pharmaceuticals, Inc.
Healthcare · Biotechnology
$5.74
Down-$0.00 (-0.04%)
Updated Nov 4, 2026, 7:51 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.04B
- P/E ratio
- -3.89
- Dividend yield
- 0.00%
- 52-week range
- $5.02 – $18.31
- Volume
- 2.17M
- Avg. volume
- 1.06M
Price performance · PHAT
PHAT price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
PHAT closed at $5.74 after 21 trading sessions, down 15.34% for the selected period.
- Last close
- $5.74
- Period change
- -15.34%
- Period low
- $5.74
- Period high
- $7.50
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $5.92 | $6.11 | $5.50 | $5.74 | 2.17M |
| Nov 2, 2026 | $5.76 | $5.925 | $5.495 | $5.915 | 2.81M |
| Oct 30, 2026 | $6.32 | $6.32 | $5.59 | $5.74 | 1.62M |
| Oct 29, 2026 | $7.00 | $7.00 | $5.71 | $6.22 | 3.84M |
| Oct 28, 2026 | $5.94 | $6.43 | $5.85 | $6.28 | 2.08M |
| Oct 27, 2026 | $5.91 | $6.18 | $5.81 | $5.99 | 2.1M |
| Oct 26, 2026 | $5.70 | $6.06 | $5.70 | $5.94 | 2.11M |
| Oct 23, 2026 | $6.72 | $6.76 | $5.015 | $5.74 | 4.87M |
| Oct 22, 2026 | $7.04 | $7.2173 | $6.965 | $7.01 | 811.71K |
| Oct 21, 2026 | $7.31 | $7.48 | $7.01 | $7.03 | 784.18K |
| Oct 20, 2026 | $7.04 | $7.40 | $6.96 | $7.31 | 724.32K |
| Oct 19, 2026 | $6.88 | $7.05 | $6.78 | $7.01 | 1.02M |
| Oct 16, 2026 | $7.51 | $7.5699 | $6.90 | $6.92 | 1.25M |
| Oct 15, 2026 | $7.54 | $7.69 | $7.41 | $7.50 | 1.21M |
| Oct 14, 2026 | $6.97 | $7.72 | $6.9178 | $7.40 | 1.72M |
| Oct 13, 2026 | $7.14 | $7.16 | $6.86 | $7.00 | 1.95M |
| Oct 12, 2026 | $7.25 | $7.285 | $7.03 | $7.13 | 1.01M |
| Oct 9, 2026 | $7.13 | $7.30 | $7.015 | $7.25 | 928.34K |
| Oct 8, 2026 | $6.79 | $7.18 | $6.68 | $7.13 | 1.33M |
| Oct 7, 2026 | $6.87 | $7.03 | $6.60 | $6.81 | 1.63M |
| Oct 6, 2026 | $6.75 | $6.80 | $6.52 | $6.78 | 2.09M |
Latest PHAT news
The latest Smart Investors Daily articles mentioning PHAT.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

